Door-to-Balloon Alliance initiative linked to better door-to-balloon times in patients with STEMI undergoing PCI

February 2010
Cardiology Today;Feb2010, Vol. 13 Issue 2, p17
The article discusses research on the significant improvement in door-to-door balloon times after the implementation of a Door-to-Balloon initiative in patients hospitalized with ST segment elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention, with a reference to a study by E. Bradley that was published in an issue of the "Journal of the American College of Cardiology."


Related Articles

  • Prospective 'real world' registry for the use of the 'PCB only' strategy in small vessel de novo lesions. Zeymer, U.; Waliszewski, M.; Spiecker, M.; Gastmann, O.; Faurie, B.; Ferrari, M.; Alidoosti, M.; Palmieri, C.; Heang, T. N.; Ong, P. J. L.; Dietz, U. // Heart;Feb2014, Vol. 100 Issue 4, p311 

    Background This prospective registry assessed the safety and efficacy of paclitaxel coated balloon (PCB) angioplasty for small vessel coronary artery disease in Europe and Asia with the intention to treat lesions without additional stenting. The use of PCBs in small vessels seems to be...

  • The index of microvascular resistance identifies patients with periprocedural myocardial infarction in elective percutaneous coronary intervention. Layland, Jamie J.; Whitbourn, Robert J.; Burns, Andrew T.; Somaratne, Jithendra; Leitl, Georg; MacIsaac, Andrew I.; Wilson, Andrew // Heart;Oct2012, Vol. 98 Issue 20, p1492 

    Background: This study was designed to assess whether measurement of the index of microvascular resistance (IMR) could help prospectively identify patients who develop periprocedural myocardial infarction (PPMI). Methods and results: IMR was measured in 54 patients before and following...

  • Early vs. delayed ace inhibitor therapy in patients with acute MI. Zeldis, Steven M.; Steingart, Richard M.; Pfeffer, MA; Greaves, SC; Arnold, JMO // Cortlandt Forum;02/25/98, Vol. 11 Issue 2, p50 

    Opinion. Comments on the results of a study published in the `Circulation' periodical which demonstrates the feasibility and safety of early angiotensin-converting enzyme (ACE) inhibition therapy in patients with acute myocardial infarction. Reduction of the frequency of hypotensive episodes...

  • Delay in Seeking MI Treatment Is Tied To Social Factors. Boyd, Leslie // RN;Oct2000, Vol. 63 Issue 10, p20 

    Focuses on a study of North American and Australian patients with acute myocardial infarction. Marked differences in the length of time patients wait before seeking treatment; Collection of data from patients' hospital records and from written questionnaires; Differences in decision-making...

  • Dilation with the Gruntzig Balloon Catheter for Peripheral Arterial Disease: Initial Experience in a Community Hospital. Calvin, James W.; Sommer, Daniel G.; Brown, Michael J. // Vascular Surgery;Jan/Feb1982, Vol. 16 Issue 1, p36 

    Intraluminal dilation using the Gruntzig catheter is a definitive procedure to correct obstructive arterial disease. Eleven procedures in 8 patients are reported. Six patients had progressive claudication and/or night pain, and 2 had advanced pre-gangrenous changes. Ihac, femoral, and/or...

  • Treatment of Renovascular Hypertension by Transluminal Renal Artery Dilatation. Mahler, Felix; Krneta, Alex; Haertel, Michael // Annals of Internal Medicine;Jan79, Vol. 90 Issue 1, p56 

    Reports on the case of a patient with renovascular hypertension treated by transluminal renal artery dilatation. Clinical profile of the patient; Instruments used during the surgery; Hazards that the procedure may pose.

  • Cutting Balloon Angioplasty for the Treatment of In-Stent Restenosis in Diabetics: A Matched Comparison of 6 Months' Outcome With Conventional Balloon Angioplasty. Cin, Veli Gokhan; Pekdemir, Hasan; Akkus, Mehmet Necdet; Camsari, Ahmet; Doven, Oben; Yenihan, Senay // Angiology;Aug/Sep2006, Vol. 57 Issue 4, p445 

    Ranging from 24% to 55%, angiographic in-stent restenosis (ISR) rates in diabetics are higher than the 17% to 28% rates observed in nondiabetics. There are controversies regarding optimal treatment for ISR. Recently, cutting balloon angioplasty (CBA) emerged as a tool in management. The authors...

  • Amlodipine: hearty savings in PTCA.  // PharmacoEconomics & Outcomes News;5/6/2006, Issue 502, p3 

    The article discusses research being done on pharmacoeconomic consequences of amlodipine besylate therapy in patients undergoing percutaneous transluminal coronary angioplasty. It references a study by F. Rossetti et al published in the March 2006 issue of "Pharmacological Research." It cites...

  • Higher doses of CD34+ cells improved functional recovery from STEMI.  // Cardiology Today;Nov2010, Vol. 13 Issue 11, p25 

    The article discusses a study which examined the effectiveness of higher doses of CD34+ cells in improving resting perfusion in patients with ST elevation myocardial infarction.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics